Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 9(126), p. 3207-3218
DOI: 10.1172/jci86249
4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
DOI: 10.1183/13993003.congress-2016.oa262
Links
- ORCID
- ORCID
- ORCID
- ORCID
- ORCID
- American Society for Clinical Investigation | PDF
- European Respiratory Society
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
Journal article published in 2016 by
Carole Phan,
Christophe Guignabert 
,
Andrei Seferian,
Alice Huertas ,
Raphaël Thuillet,
Ly Tu ,
Caroline Sattler,
Morane Le Hiress,
Morane Le Hiress,
Yuichi Tamura,
Etienne-Marie Jutant ,
Marie-Camille Chaumais,
Stéphane Bouchet,
Benjamin Manéglier,
Mathieu Molimard
and other authors.
,
Andrei Seferian,
Alice Huertas ,
Raphaël Thuillet,
Ly Tu ,
Caroline Sattler,
Morane Le Hiress,
Morane Le Hiress,
Yuichi Tamura,
Etienne-Marie Jutant ,
Marie-Camille Chaumais,
Stéphane Bouchet,
Benjamin Manéglier,
Mathieu Molimard
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 